• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: auranofin
Date Designated: 04/30/2010
Orphan Designation: Treatment of amebiasis
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Ctr for Discovery & Innovation in Parasitic Diseas
U. of CA, San Francisco
QB3, Byers Hall 508B
San Francisco, California 94158
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.